Agarwal Arjun sold ORKA
September 15, 2026 · Form 4 insider transaction
Agarwal Arjun sold 560 shares of Oruka Therapeutics, Inc. at $95.71 per share, a transaction worth $53.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
560
Price
$95.71
Total value
$53.6K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 15, 2026
Filing dateSeptember 15, 2026
Shares owned after14,752
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.